[Influenza vaccination rates of patients with statutory ambulatory medical care in protective facilities and in nursing and special care homes].

Influenzaimpfquoten von Patienten mit vertragsärztlicher Versorgung in beschützenden Einrichtungen, Pflege- und Altenheimen.
Ambulatory medical care Elderly Influenza vaccination coverage Patient in nursing homes Routine data

Journal

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
ISSN: 1437-1588
Titre abrégé: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Pays: Germany
ID NLM: 101181368

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 1 12 2018
medline: 13 9 2019
entrez: 1 12 2018
Statut: ppublish

Résumé

Vaccination is one of the most important and effective preventive measures against seasonal influenza. The German Standing Committee on Vaccination (STIKO) recommends influenza vaccination for specific groups of patients, including those in protective facilities and nursing or special care homes ("bPA-facilities"). The defined aim of the European Commission (EC) is vaccination coverage of 75% or higher among the elderly. In Germany, vaccination rates in bPA-facilities are currently based on surveys in limited samples of patients. The aim of the present study is to gain better insight into nationwide influenza vaccination rates. Specifically, we aim to identify influenza vaccination coverage of patients with ambulatory medical care in bPA-facilities. The present analysis is a descriptive analysis of Germany's billing data of all ambulatory statutory health insurance physicians (ASHIP) for six study cohorts from 2010 to 2016. On average, 58.5% of patients in bPA-facilities received an influenza vaccination between 2010 (60.3%) and 2016 (56.6%), with strong differences between different ASHIP billing areas (up to 20 percentage points(pp)) and patients who consulted a general practitioner (up to 35 pp). These results provide initial insights into vaccination coverage in bPA-facilities and show associations between the structural differences in care setting and the use of influenza vaccines. Furthermore, they can help to identify groups with low influenza vaccination rates and complement existing data thereby assisting health policy in increasing vaccination coverage. The present study group has not yet reached the EC goal of 75% influenza vaccination coverage.

Sections du résumé

BACKGROUND BACKGROUND
Vaccination is one of the most important and effective preventive measures against seasonal influenza. The German Standing Committee on Vaccination (STIKO) recommends influenza vaccination for specific groups of patients, including those in protective facilities and nursing or special care homes ("bPA-facilities"). The defined aim of the European Commission (EC) is vaccination coverage of 75% or higher among the elderly. In Germany, vaccination rates in bPA-facilities are currently based on surveys in limited samples of patients.
OBJECTIVES OBJECTIVE
The aim of the present study is to gain better insight into nationwide influenza vaccination rates. Specifically, we aim to identify influenza vaccination coverage of patients with ambulatory medical care in bPA-facilities.
MATERIAL AND METHODS METHODS
The present analysis is a descriptive analysis of Germany's billing data of all ambulatory statutory health insurance physicians (ASHIP) for six study cohorts from 2010 to 2016.
RESULTS RESULTS
On average, 58.5% of patients in bPA-facilities received an influenza vaccination between 2010 (60.3%) and 2016 (56.6%), with strong differences between different ASHIP billing areas (up to 20 percentage points(pp)) and patients who consulted a general practitioner (up to 35 pp).
CONCLUSIONS CONCLUSIONS
These results provide initial insights into vaccination coverage in bPA-facilities and show associations between the structural differences in care setting and the use of influenza vaccines. Furthermore, they can help to identify groups with low influenza vaccination rates and complement existing data thereby assisting health policy in increasing vaccination coverage. The present study group has not yet reached the EC goal of 75% influenza vaccination coverage.

Identifiants

pubmed: 30498849
doi: 10.1007/s00103-018-2854-4
pii: 10.1007/s00103-018-2854-4
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

84-93

Auteurs

Diana Kurch-Bek (D)

Innovation, strategische Analyse und IT-Beratung, Kassenärztliche Bundesvereinigung, Herbert-Lewin-Platz 2, 10623, Berlin, Deutschland. dkurch-bek@kbv.de.

Christian Gallowitz (C)

Innovation, strategische Analyse und IT-Beratung, Kassenärztliche Bundesvereinigung, Herbert-Lewin-Platz 2, 10623, Berlin, Deutschland.

Bernhard Tenckhoff (B)

Innovation, strategische Analyse und IT-Beratung, Kassenärztliche Bundesvereinigung, Herbert-Lewin-Platz 2, 10623, Berlin, Deutschland.

Leonie Sundmacher (L)

Fachbereich Health Services Management, Ludwig-Maximilians-Universität München, Schackstraße 4, 80539, München, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH